Neodynamics
0.914 SEK -2.35%HC Andersen Capital receives payment from Neodynamics for a DigitalIR/Corporate Visibility agreement. See disclaimer.
7 investors are following this company
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Revenue
320K
EBIT %
-28,425 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
NEOD
Daily low / high price
0.89 / 0.938
SEK
Market cap
29.81M SEK
Turnover
1.95K SEK
Volume
2.1K
Analyst
Claus Thestrup
CEO, Sweden
Latest videos
Financial calendar
Interim report
07.05.2024
General meeting
22.05.2024
Interim report
20.08.2024
Interim report
19.11.2024
Annual report
17.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gryningskust Holding AB | 32.9 % | 32.9 % |
Rentability Sweden AB | 4.0 % | 4.0 % |
Premium
This content is for our Premium customers only.
Forum updates
ShowingAll content types
Salénterprise increases its shareholding in NeoDynamics.
NeoDynamics announces the final outcome regarding the exercise warrants of series TO3
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools